Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead

by Petr Novak, Petr Novak, Eva Kontsekova, Eva Kontsekova, Norbert Zilka, Norbert Zilka, Michal Novak, Michal Novak
Published 2018-11-01

Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2

by Nikola Hudakova, Simona Hricikova, Amod Kulkarni, Mangesh Bhide, Eva Kontsekova, Dasa Cizkova
Published 2021-05-01

Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans

by Petronela Weisová, Ondrej Cehlár, Rostislav Škrabana, Monika Žilková, Peter Filipčík, Branislav Kováčech, Michal Prčina, Ľubica Wojčiaková, Ľubica Fialová, Tomáš Smolek, Eva Kontseková, Norbert Žilka, Michal Novák
Published 2019-08-01

A walk through tau therapeutic strategies

by Santosh Jadhav, Jesus Avila, Michael Schöll, Gabor G. Kovacs, Enikö Kövari, Rostislav Skrabana, Lewis D Evans, Eva Kontsekova, Barbara Malawska, Rohan de Silva, Luc Buee, Norbert Zilka
Published 2019-02-01

Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation

by Monika Zilkova, Anna Nolle, Branislav Kovacech, Eva Kontsekova, Petronela Weisova, Peter Filipcik, Rostislav Skrabana, Michal Prcina, Tomas Hromadka, Ondrej Cehlar, Gabriela Paulikova Rolkova, Denisa Maderova, Michal Novak, Norbert Zilka, Jeroen J. M. Hoozemans
Published 2020-05-01

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease

by Petr Novak, Reinhold Schmidt, Eva Kontsekova, Branislav Kovacech, Tomas Smolek, Stanislav Katina, Lubica Fialova, Michal Prcina, Vojtech Parrak, Peter Dal-Bianco, Martin Brunner, Wolfgang Staffen, Michael Rainer, Matej Ondrus, Stefan Ropele, Miroslav Smisek, Roman Sivak, Norbert Zilka, Bengt Winblad, Michal Novak
Published 2018-10-01